This study will explore the impact of an exercise and nutrition (EX+NUTR) , relative to exercise alone (EX) intervention, on brain structure and function as well as blood biomarkers in older adults with subjective cognitive decline (SCD) and vascular risk factors. The overall hypotheses are that a combined EX+NUTR, relative to EX, intervention will evoke more positive changes in brain structure (e.g. hippocampal volume), neural activity (e.g. task associated functional activations monitored through fMRI), and cognitive performance. These changes will be associated with an improved metabolic profile, reductions in inflammatory cytokines and oxidative burden, and greater intervention compliance.
All participants will engage in group supervised exercise sessions once per week as well as engage in additional exercise sessions at home 4 days/week. The exercise program will be run out of two sites (Toronto Rehabilitation Institute (TRI) - Rumsey Centre in Toronto, and the Centre for Community, Clinical Applied Research Excellence (CCCARE) at the University of Waterloo). The supervised exercise sessions modeled after the standard TRI Cardiovascular Prevention and Rehabilitation program, including aerobic training, resistance training and education/counseling. The active group will receive strategy training to simultaneously improve their diet in conjunction with our newly developed Brain Health Food Guide (EX+BHFG); the placebo control group (EX+BHEd) will receive brain health education to control for time and social participation. \[NOTE All participants must also be enrolled in the SCD cohort of the CCNA and undergo the CCNA's COMPASS-ND assessment at the beginning of the trial.\] The study is 6 months in duration and requires participants to attend 2.5 hr weekly sessions (1 hr supervised exercise, 0.5 hr exercise/stress education and 1 hr nutrition or brain health education) and to exercise on their own an additional 3-4 times per week. Participants are assessed on measures of cognition, brain health (MRI), functional status at baseline, post intervention and 6 month follow-up.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Enrollment
14
On the same day as the exercise class, participants will also receive nutrition support. Participants will alter their overall diet to be consistent with recommendations outlined in our brain health food guide (BHFG) and receive diet counseling and strategy training to promote retention and enable this dietary change. For the first two months, diet group sessions will be held on a weekly basis. For the remaining four months, sessions will be divided between group sessions and individual meetings with study dietitians, on a predefined schedule. Participants will submit weekly logs outlining diet goals, plans, successes and obstacles to help direct identification of sequential goals.
Supervised group exercise will be performed once per week (60 minutes) and self-directed exercise (4 additional aerobic and 2-3 resistance training sessions per week) will be monitored by an exercise diary. The initial walking prescription will be set at \~1.6 km and an intensity equivalent to the anaerobic threshold and/or 60% VO2-peak. Progressions will be made every 2 weeks, increasing distance to a maximum of 6.4 km and then increasing to a max intensity of 80% of VO2-peak and/or max duration of 60 minutes. Heart rate and perceived exertion will be monitored. The program will last 6 months.
Toronto Rehabilitation Institute Rumsey Centre
Toronto, Ontario, Canada
Sunnybrook Health Sciences Centre
Toronto, Ontario, Canada
Rotman Research Institute
Toronto, Ontario, Canada
Centre for Community, Clinical Applied Research Excellence (CCCARE) at the University of Waterloo
Waterloo, Ontario, Canada
Changes from baseline brain structure at 6 months and 12 months.
Cortical and subcortical grey matter density using MRI three-dimensional T1 weighted structural scan (MPRAGE)
Time frame: 6 months plus 6 month follow-up
Changes from baseline cerebral blood flow at 6 months and 12 months.
Pseudo-continuous arterial spin labeling MRI (pcASL) to quantify cerebral blood flow
Time frame: 6 months plus 6 month follow-up
Changes from baseline cognition at 6 months and 12 months
pen and paper and computerized tasks, monitoring memory, executive function, and speed of processing. The results will be presented as a composite score of total neuro-psychological performance aggregating scores from the above cognitive domains.
Time frame: 6 months plus 6 month follow-up
Changes from baseline brain activity related to attention at 6 months and 12 months
BOLD functional MRI while participants performing an attention task
Time frame: 6 months plus 6 month follow-up
Changes from baseline resting state connectivity at 6 months and 12 months
BOLD functional MRI while participants at rest
Time frame: 6 months plus 6 month follow-up
Changes from baseline diet quality at 6 months and 12 months
Principle component analyses based on Canadian Diet History Questionnaire II (C-DHQII)
Time frame: 6 months plus 6 month follow-up
Changes from baseline adherence to diet recommendations at 6 months and 12 months
Principle component analyses based on the Eating Pattern Self-Assessment
Time frame: 6 months plus 6 month follow-up
Changes from baseline grip strength at 6 months and 12 months
Grip strength using a hand held dynamometer
Time frame: 6 months plus 6 month follow-up
Changes from baseline gait performance at 6 months and 12 months
Gait velocity, stride length/width, and associated variability assessed using a GAITRite pressure sensor mat.
Time frame: 6 months plus 6 month follow-up
Changes from baseline balance performance at 6 months and 12 months
Posturography assessment on balance platform
Time frame: 6 months plus 6 month follow-up
Changes from baseline maximal oxygen uptake at 6 months and 12 months
VO2max determined during cardiopulmonary assessment
Time frame: 6 months plus 6 month follow-up
Changes from baseline blood moderators at 6 months and 12 months
e.g. BDNF, pro-BDNF, ApoE,
Time frame: 6 months plus 6 month follow-up
Changes from baseline HbA1C at 6 months and 12 months
HbA1C
Time frame: 6 months plus 6 month follow-up
Changes from baseline fasting glucose at 6 months and 12 months
fasting glucose
Time frame: 6 months plus 6 month follow-up
Changes from baseline insulin levels at 6 months and 12 months
insulin
Time frame: 6 months plus 6 month follow-up
Changes from baseline lipid levels at 6 months and 12 months
lipid profile
Time frame: 6 months plus 6 month follow-up
Changes from baseline homocysteine levels at 6 months and 12 months
homocysteine
Time frame: 6 months plus 6 month follow-up
Changes from baseline C reactive protein levels at 6 months and 12 months
CRP
Time frame: 6 months plus 6 month follow-up
Changes from baseline TNF-alpha levels at 6 months and 12 months
TNF-alpha
Time frame: 6 months plus 6 month follow-up
Changes from baseline IL6 levels at 6 months and 12 months
IL6
Time frame: 6 months plus 6 month follow-up
Changes from baseline vitamin K levels at 6 months and 12 months
Vitamin K
Time frame: 6 months plus 6 month follow-up
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.